Welcome to our Cannabis Earnings series where we break down the latest earnings to help you focus on the most important topics.
Introduction
OrganiGram (OGRMF) just proved to its Canadian peers that action speaks louder than words with its latest quarterly results. We were impressed by the strong execution at OrganiGram including its ability to capture a meaningful share of the recreational market while many others struggled. We reiterate our favorable near-term view on the stock and believe the momentum will continue in the next few quarters.
(All amounts in C$)